GSN and gastric adenocarcinoma: For DSS, low GSN expression was a negative factor affecting DSS in patients with CESC, KIRC, SARC, and UCEC, while it is a preventative variable for BLCA, LGG, and STAD patients (p < 0.05; Figure 4B and Supplementary Figure S1B).